Background/Aims: Stem cell-derived exosomes (EXs) offer protective effects on various cells via their carried microRNAs (miRs). Meanwhile, miR-210 has been shown to reduce mitochondrial reactive oxygen species (ROS) overproduction. In this study, we determined the potential effects of endothelial progenitor cell-derived EXs (EPC-EXs) on hypoxia/ reoxygenation (H/R) injured endothelial cells (ECs) and investigated whether these effects could be boosted by miR-210 loading. Methods: Human EPCs were used to generate EPCEXs, or transfected with scrambler control or miR-210 mimics to generate EPC-EXs sc and EPCEXs miR-210 . H/R-injured human ECs were used as a model for functional analysis of EXs on apoptosis, viability, ROS production and angiogenic ability (migration and tube formation) by flow cytometry, MTT, dihydroethidium and angiogenesis assay kits, respectively. For mechanism analysis, the mitochondrion morphology, membrane potential (MMP), ATP level and the expression of fission/fusion proteins (dynamin-related protein 1: drp1 and mitofusin-2: mfn2) were assessed by using JC-1 staining, ELISA and western blot, respectively. Results: 1) Transfection of miR-210 mimics into EPCs induced increase of miR-210 in EPC-EXs 
Introduction
Endothelial progenitor cells (EPCs) are known to play an important role in modulating the function of endothelial cells (ECs) [1] . The potential mechanisms have been attributed to their ability of differentiation into ECs to replace the injured or dysfunctional ECs [2, 3] and their secretion of growth factors (vascular endothelial growth factor et.) to promote angiogenesis [4] . Most recently, extracellular microvesicles have been recognized as a novel way of cell-cell communication [5, 6] . EPC-derived microvesicles can protect kidneys from ischemia/reperfusion injury [7] and improve neovascularization in a murine model of hindlimb ischemia through their shuttled microRNAs (miRs), miR-126 and miR-296 [8] . Our group has demonstrated that EPC-released extracellular vesicles could protect ECs against hypoxia/reoxygenation (H/R) injury, which is at least in part mediated by their carried miR-126 [9] .
Exosomes (EXs) is one type of extracellular microvesicles which could modulate the functions of recipient cells via transferring their cargoes, such as miRs, proteins and mRNAs [5, 6] . Stem cells released EXs have been shown to execute the beneficial effects of their parent cells in stem cell-based therapy [10, 11] . Mesenchymal stem cell-derived EXs have been reported to promote neurological protection via conveying miR-133 to neural cells in a stroke rat model [12] . EXs derived from inducible pluripotent stem cells can prevent cardiomyocyte apoptosis through delivery miR-210 in the ischemic myocardium [13] . However, whether EPC-EXs have protective effects on H/R-injured ECs remains unknown.
Several studies have suggested that miR-210 plays a critical role in regulating the EC responses to hypoxia [14] [15] [16] [17] [18] . MiR-210 can decrease the apoptosis and angiogenic dysfunction of ECs induced by hypoxia [16] . Overexpression of miR-210 could enhance the microvessel density in the ischemic stroke mouse [17] and the angiogenesis in a myocardial infarction mice model [18] . A clinical study showed that the level of circulating miR-210 was positively related to the outcome of stroke patients [19] . Interestingly, EXs derived from breast cancer cells could enhance the angiogenic function of ECs by transferring miR-210 [20] . There is evidence showing that miR-210 promotes cell survival through reducing hypoxia-induced overproduction of mitochondrial reactive oxygen species (ROS) [21] . Therefore, upregulation of miR-210 in EPC-EXs might be a novel strategy to enhance the beneficial effects of EPC-EXs on H/R-injured ECs.
Mitochondria are essential organelles and play a significant role in a wide range of cells, including ECs and cardiomyocytes [22] [23] [24] . EC injury induced by ischemia-reperfusion and EC dysfunction in diabetes mellitus are associated with mitochondrial ROS overproduction [25] and mitochondrial fragmentation [24] . A recent study demonstrated that diffusion of mitochondria-derived ROS into the nucleus contributes to the regulation of hypoxia sensitive genes in rat pulmonary ECs [26] . Of note, miR-210 has been shown to be able to reduce mitochondrial ROS overproduction, suggesting the role of miR-210 in mitochondrial function [21] . Nevertheless, whether miR-210 could protect mitochondrial function to boost the beneficial effects of EPC-EXs on ECs remains unclear.
In this study, we determined whether EPC-EXs can protect ECs against H/R injury and investigate whether miR-210 enrichment could boost these effects through improving mitochondrial function.
Materials and Methods

Cell culture and transfection
Human EPCs were purchased from Celprogen (Torrance, CA) and cultured in complete growth medium (Celprogen; Torrance, CA) according to the manufacturer's protocol. Medium was changed every other day. Human brain ECs were purchased from Cell Systems (Kirkland, WA) and cultured with CSC complete medium (Cell Systems; Kirkland, WA) containing 10% serum, 2% human recombinant growth factors, and 0.2% antibiotic solution under standard cell culture conditions (5% CO2, 37°C). Medium was changed twice a week.
To overexpress miR-210, human EPCs were cultured to 60-70% confluence, and transfected with miR-210 mimic or the scramble control (SC) (10 nM, Dpharmacon, Lafayette, CO) using Dharmacon transfection reagents (Dharmacon, Lafayette, CO) for 48 hrs according to the manufacturer's instruction. EPCs cultured in complete culture medium served as control. The three types of EPCs were used for producing corresponding EXs.
Preparation and collection of EPC-EXs
The protocol for collecting EXs from serum-free culture medium has been reported in a previous study [27] . Briefly, the three types of EPCs were cultured in serum-free culture medium for 24 hrs. Then, the culture medium was centrifuged at 300 g, 15 mins to remove dead cells. The supernatants were then centrifuged at 2000 g, 30 mins to remove cell debris, followed by centrifugation at 20, 000 g, 70 mins, and ultracentrifugation at 170, 000 g, 90 mins to pellet EXs. The pelleted EXs were denoted as EPC-EXs, EPCEXs sc or EPC-EXs miR-210
. All EXs were resuspended with phosphate-buffered saline (PBS) and aliquoted for nanoparticle tracking analysis (NTA) and for co-culture experiments. PBS was filtered through 20 nm-filter (Whatman, Pittsburgh, PA).
Nanoparticle tracking analysis
The NanoSight NS300 (Malvern Instruments, Malvern, UK) was used to analyze the size and CD63 expression of EXs as previously described [27, 28] . To detect CD63 expression in the EXs, the collected EXs were incubated with CD63-conjugated microbeads (10 ul; Miltenyi Biotec) in a 100-µl reaction volume for 2 hrs. A magnet (DynaMag-2 magnet; Life technology) was then applied to separate the CD63 + EXs from the total EX suspension. After an overnight magnet separation, the CD63 + EXs were resuspended in100 µl of filtered PBS and incubated with rabbit anti-goat IgG conjugated with Q-dot 655 (1:350; Life Technologies) for 90 mins at RT. All samples were then analyzed using the NTA fluorescence-scatter mode. Three 30-second videos of were taken with a frame rate of 30 frames per second. The Data were analyzed using NTA 3.0 software (Malvern Instruments, Malvern, UK) on a frame-by-frame basis.
Hypoxia/reoxygenation injury model in ECs
The EC injury model was induced as previously described [9] . In brief, ECs were cultured in hypoxia for 6 hrs in a hypoxic chamber (1% O 2 , 5%CO 2 , and 94%N 2 ; Biospherixhypoxia chamber, NY) and then reoxygenated by incubation in a standard 5% CO 2 incubator for 24 hrs. During the reoxygenation period, ECs were treated with the different types of EPC-EXs.
Co-incubation Design
H/R-injured ECs were divided into four co-culture groups: vehicle (co-culture medium only), EPCEXs, EPC-EXs . EPC-EXs were labeled with a red fluorescence dye PKH 26 and then were resuspended with CSC medium and added to the culture medium of ECs during the reoxygenation period. In brief, EXs were labeled with PKH 26 (2 x 10 -6 M, Sigma-Aldrich) for 5 mins at 37 °C, followed by wash with 1 x PBS and ultracentrifuged at 170, 000g for 90 mins. The concentration of EPC-EXs (50 μg/ml) was determined based on our previous study [29] . After 24 hr of co-culture, the incorporation of EPC-EXs into ECs was observed under a fluorescence microscope (EVOS; Thermo Fisher Scientific). The fluorescence intensity of ECs was analyzed using Image J as reported [28] . ECs were then used for various tests as described below.
Quantitative RT-PCR analysis
The RNAs from EPCs and their released EXs, as well as from ECs after co-incubation with various EPC-EXs were extracted using Trizol (Thermo Fisher Scientific). For determining miR-210 level, reverse transcription (RT) reactions were performed using PrimeScript TM RT reagent kit (TaKaRa, Japan) and PCR reactions were conducted using SYBR Premix EX Taq TM II kit (TaKaRa, Japan). The RT primer was: 5'-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTG GATACGACGACTGT-3'. The forward primer of miR-210 was: 5'-CACGCAGTCGTA TCCAGTGCAGG-3'. The reverse primer of miR-210 was: 5'-CCAGTGCAGGGTCCG AGGTA-3'. The expression of U6 was used as endogenous control for each sample. The forward primer of U6 was: 5'-CTCGCTTCGGCAGCACA-3', the reverse primer of U6 was: 5'-AACGCTTCACGAATTTGCGT-3'. Relative expression level of each gene was normalized to U6 and calculat ed using the 2 -ΔΔCT method.
Apoptosis Assay
After 24 hr of co-culture, ECs were detached for apoptosis assay by using the FITC Annexin V apoptosis detection kit (BD Biosciences, CA) [29] and analyzed by flow cytometry. The percentage of apoptotic cells was calculated as: Annexin V+/PI− cells/ total cells x 100%.
Measurement of ROS production
Intracellular ROS production was determined by dihydroethidium (DHE) (Sigma) staining [9] and analyzed by flow cytometry. Data are expressed as fold of control in fluorescent intensity. ECs cultured with CSC medium under normoxic condition were used as controls. 
Cell Viability Analysis
The angiogenic functional assays of ECs
The tube formation assay was conducted using in vitro angiogenesis assay kit (Chemicon, Rosemont, IL) [9] . The migration ability of ECs was determined by scratch assay [30] . In brief, ECs were grown to confluence on 6-well cell culture plates. A scratch was made through the cell monolayer using a 1000 µl pipette tip. After washing with PBS, cells were treated with the various types of EPC-EXs or culture medium only (vehicle). Photographs of the wounded area were taken immediately (0-hr time point) and 16 hr after making the scratch. The migration ability was determined by monitoring the invasion of cells into the scratched area.
Detection of ATP levels
Cellular ATP levels were measured using an ATP Assay Kit (Promega, WI, USA) according to the manufacturer's instruction. Briefly, the proteins of ECs treated with various types of EPC-EXs were harvested and determined by the BCA assay (Thermo Scientific). In 6-well plates, 200 μl protein supernatant was mixed with 100 μl ATP detection working solution. The luminance (RLU) was measured by a fluorescence microplate reader (Thermo Fisher Scientific, Varioskan Flash, USA). The total ATP levels were expressed as nmol/mg protein. The relative ATP level was calculated according to the following formula: relative ATP level = ATP value / protein concentration.
Analysis of mitochondrial membrane potential
The mitochondrial membrane potential (MMP) of ECs treated with various types of EPC-EXs was measured using the lipophilic cationic dye JC-1 (1:1000, Invitrogen) [31] . In brief, after 24-hr of treatment, ECs were washed with PBS and incubated with 1 ml of medium containing JC-1 staining probe (2 µM final concentration) for 20 mins at 37 °C. The cells were then washed with PBS and observed under a fluorescence microscope (EVOS; Thermo Fisher Scientific). The level of cellular fluorescence intensity was analyzed Cellular Physiology and Biochemistry
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by Image J (NIH, Bethesda, MD). The relative MMP was calculated as the ratio of J-aggregate to monomer (590/520 nm). Values are expressed as fold increase in the ratio of J-aggregate to monomer fluorescence relative to control cells. ECs cultured with CSC medium were used as controls. The original images were all taken with the same gain/intensity with the same threshold. The people who did the analysis was blinded to the grouping information.
Assessment of mitochondrial morphology
To assess mitochondrial morphology, ECs growing on coverslips were stained with MitoTracker as previous reports [32] . In brief, cells were pre-incubated with MitoTracker Green FM (100 nM; Invitrogen) for 15 mins, and then fixed in 4% paraformaldehyde (PFA) for 10 mins at RT. The nucleus was then counterstained with 4', 6-Diamidino-2-Phenylindole (DAPI). Mitochondrial morphology was observed under 60 x oil immersion objective of a confocal microscope (Olympus FV-1000, Japan). Digital images were subjected to a convolve filter through the IMAGEJ software (NIH) to isolate and equalize fluorescent pixels in the image [33] . After thresholding, individual particles (mitochondria) were analyzed for circularity (4p ´ Area / (perimeter 2 )) and lengths of major and minor axes. From these values, we calculated form factor (FF; the reciprocal of circularity value) and aspect ratio (AR; major/minor). Both FF and AR have a minimal value of 1 when a particle is a small perfect circle and the values increase as the shape becomes elongated. A minimum of 100 cells from 10 random microscopic fields (60x) were assessed for mitochondrial fragmentation per co-culture group in each independent experiment. Six independent experiments were conducted in each group.
Western blot analysis
After 24-hour of treatment, proteins of ECs in different groups were extracted with cell lysis buffer (Thermo Fisher scientific, Waltham, MA) supplemented with complete mini protease inhibitor tablet (Roche, Basel, Switzerland). Then, the protein lysates were electrophoresed through SDS-PAGE gel and transferred onto PVDF membranes. The membranes were blocked with 5% non-fat milk for 1 hr at room temperature, and incubated with primary antibody against mitofusin-2 (mfn2: 1:1000; Thermo Fisher Scientific), dynamin-related protein 1 (drp1, 1:1000; Thermo Fisher Scientific) or b-actin (1:4000; Sigma, St. Louis, MO) at 4ºC overnight. On the next day, membranes were washed and incubated with horseradishperoxidase-conjugated anti-rabbit or anti-mouse IgG (1:40000; Jackson Immuno Research Lab, West Grove, PA) for 1 hr at room temperature. Blots were developed with enhanced chemiluminescence developing solutions and images were quantified using ImageJ software.
Statistical analysis
All experiments were repeated for four to six times. Data are expressed as the mean ± SEM. Multiple comparisons were analyzed by one-or two-way ANOVA followed by Tukey post-hoc test. SPSS 23.0 statistical software was used for analyzing the data. For all measurements, p<0.05 was considered statistic significant.
Results
Characterization of EPC-EXs
As shown in According to the NTA analysis, the average diameter of the three types of EXs was less than 120 nm (Fig. 1B) , and there was no difference of the size among EPC- 
, reflecting that miR-210 transfection did not affect the size of the released EXs. In addition, our data showed that the majority (> 80%) of these EXs expressed EX specific marker CD63 as revealed by fluorescent NTA analysis (Fig.  1C) .
EPC-EXs miR-210 co-incubation increased the miR-210 level in H/R-injured ECs
In order to track EPC-EXs in the coculture system, we labeled the collected EXs with a red fluorescence dye PKH26. After 24-hr co-incubation, we observed red fluorescence in the cytoplasm of ECs ( Fig. 2A) . Meanwhile, we analyzed the fluorescence intensity of ECs in all groups and found that there was no significant difference of the fluorescence intensity (Fig.  2B) .
As revealed by the qRT-PCR data, the level of miR-210 was slightly raised in ECs exposed to H/R than that in control ECs. After 24 hr co-incubation, there was no significant difference of miR-210 level in ECs between the vehicle and EPC-EXs or EPC-EXs sc . However, co-cultured with EPC-EXs miR-210 significantly elevated both miR-210 level in H/R-injured ECs (Fig. 2C) , indicating that co-incubation with EPCEXs miR-210 could transfer their carried miR-210 to ECs.
EPC-EXs miR-210 were more effective than EPC-EXs and EPC-EXs sc in attenuating H/R-induced EC apoptosis and ROS overproduction
As shown in Fig. 3A-3B , H/R induced a significant increase of EC apoptosis that was partially reduced by EPC-EX or EPC-EX sc treatment. Moreover, we found that EPC-EXs miR-210 almost completely inhibited H/R-induced increase of EC apoptosis.
Similarly, ROS production was elevated in ECs exposed to H/R as compared to that in control. H/R-induced ROS overproduction was significantly reduced by EPC-EX or EPC-EX sc treatment, which was further decreased by EPC-EXs miR-210 (Fig. 3C ). These data demonstrate that EPC-EXs miR-210 were more effective than EPC-EXs and EPCEXs sc in protecting ECs from H/R-induced apoptosis and oxidative stress.
EPC-EXs miR-210 were more effective than EPC-EXs and EPC-EXs sc in promoting cell viability on both normal and H/R-injured ECs
According to the MTT assay, we found that H/R decreased EC viability (vs. control; p<0.05; n=6/group; Fig. 4 ). EPC-EXs and EPC-EXs sc increased the viability of ECs in both control (normoxia) and H/R treated cells (vs. vehicle; p<0.05; n=6/group; Fig. 4) . EPCEXs miR-210 were more effective in increasing the viability of ECs (vs. EMVs; p<0.05; n=6/group; Fig. 4) . 
Angiogenic dysfunction of H/R-injured ECs was more effectively improved by EPC-EXs miR-210
To assess the angiogenic ability of ECs, we measured their tube formation and migration abilities. Our data (Fig.  5) revealed that both tube formation and migration abilities of ECs were compromised by H/R as indicated by a decreased number of tubes per field and an increased gap distance as compared to that of the control. EPC-EX or EPC-EX sc treatment could partially rescue the tube formation and migration abilities of ECs. What's more, there were no significant differences of the migration and tube formation abilities of ECs in the control and those treated by EPC-EXs miR-210 , indicating a prominent effect of EPC-EXs miR-210 on improving H/Rcompromised EC angiogenic properties.
EPC-EXs miR-210 were more effective in increasing MMP and ATP level in H/Rinjured ECs
To assess the MMP of H/R-injured ECs, we used JC-1 staining. As shown in Fig. 6A , red indicates aggregate while green indicates monomer. The MMP was calculated as the ratio of aggregate to monomer (red/green). Summarized data in Fig. 6B showed that H/R significantly decreased MMP (ΔψM, red/green) of ECs. A comparison of the ATP synthetic ability of ECs was shown in Fig. 6C . ECs exposed to H/R displayed a decreased level of ATP as compared to that of ECs cultured in normoxic condition. EPC-EX or EPC-EX sc treatment partially rescued H/R-decreased ATP level of ECs. Moreover, EPC-EX miR-210 further improved the ability of ECs to produce ATP. Taken together, EPCEXs miR-210 were more effective than EPC-EXs in maintaining mitochondrial MMP balance and function.
EPC-EXs miR-210
prominently improved H/R-induced mitochondrial fragmentation The representative pictures in Fig. 7A show the mitochondrial fragmentation (green) after different treatments. The summarized 
EPC-EXs miR-210 were prominent on modulating the expression of mitochondrial fusion and fission proteins in H/R-injured ECs
To further explore the mechanisms of fragments formation, we measured the levels of fission and fusion proteins in ECs. As shown in Fig. 8 
Discussion
In the present study, we firstly found that EPC-EXs or EPC-EXs sc exhibited beneficial effects on protecting ECs from H/R-induced injury and dysfunction. More interesting, loading of miR-210 in EPC-EXs boosted these protective effects through improving mitochondrial function of ECs.
As previously reported [9] , we reproduced the model of H/R-injured ECs which displayed increased apoptosis and ROS overproduction, accompanying with angiogenic dysfunction. It is known that MMP is a marker of mitochondrial health and mitochondrial fragmentation is a primary event in hypoxia [25] . Fusion and fission proteins, mfn2 and drp1, contribute to the maintenance of mitochondrial function [34] . In this study, we revealed that H/R-injured ECs had a dramatic loss of MMP, decreased ATP level and increased mitochondrial fragmentation. Meanwhile, mfn2 expression was significantly decreased, whereas drp1 expression was significantly increased, indicating the mitochondrion function of ECs was impaired. This is supported by a previous study showing that decreased expression of mfn2 occurred both in vivo and in vitro hypoxic models [35] . To test the protection effects of EPC-EXs, we cocultured EPC-EXs with the H/R-injured ECs and found that EPC-EXs significantly decreased H/R-induced apoptosis and ROS overproduction. These findings indicate the anti-apoptotic and anti-oxidative effects of EPC-EXs on ECs. Besides, we found that H/R-compromised angiogenic function (tube formation and migration abilities) was significantly improved by EPC-EXs. This result is in agreement with previous reports showing the protective/ therapeutic effects of stem cell-derived extracellular microvesicles [7] [8] [9] 12] . It is known that EXs can affect recipient cell function through conveying miRs [5, 6] . Interestingly, co-culture of EPC-EXs did not change the level of miR-210 in ECs, suggesting that the effects of EPCEXs were independent on miR-210. Meanwhile, we did find that EPC-EXs improved H/Rcompromised mitochondrial function as revealed by increased MMP and ATP level, reduced mitochondrial fragmentation, as well as increased mfn2 expression and decreased drp1 level. As we know, EXs carry massive RNAs and proteins. Previous reports by us and others showing that EPC-derived extracellular microvesicles shuttle miR-126 [7] [8] [9] . The protective effects of EPC-EXs on H/R-injured ECs is probably due to their carried miR-126 which has been shown to have beneficial effects on ECs/EPC survival and angiogenic function [30, 36] and have modulatory effects on mitochondrion [37] . However, whether these molecules are responsible for the observed effects of EPC-EXs need further investigation.
Using RT-PCR, we found that miR-210 was up-regulated in normal ECs compared to apoptotic ECs after H/R challenge, suggesting that miR-210 possesses anti-apoptotic properties during cell stress conditions. This data is also confirmed by a recent report indicating that miR-210 is induced in ischemia-preconditioned bone marrow derived mesenchymal stem cells [38] and hypoxia-challenged cardiomyocytes [18] . In the present study, we proposed to explore whether overexpressing miR-210 in EPC-EXs would enhance the protective of EPC-EXs. The rationale is based on followings: a) EPC transfusion has therapeutic effects on ischemic stroke [39] ; b) The potential mechanisms of stem cell therapy for ischemic stroke have been partially attributed to their released microvesicels or EXs [10, 11] ; c) EPC-released microvesicels have shown angiogenic function in ECs/EPCs by delivering their carried miR-126 [30] ; d) miR-210 has shown therapeutic potential for ischemic disease [18] . To determine the role of miR-210 in EPC-EXs, we successfully produced miR-210 enriched EPC-EXs by transfecting EPCs with miR-210 mimics. As expected, EPCEXs miR-210 were well incorporated with ECs after co-incubation. Moreover, EPC-EXs miR-210
, not EPC-EXs or EPC-EXs sc , remarkably elevated miR-210 level in ECs, indicating EPC-EXs miR-210 can elevate miR-210 level in ECs. Functional studies reveled that EPC-EXs miR-210 had better effects than EPC-EXs on rescuing ECs from H/R-induced decrease of survival and angiogenic dysfunction. Our study is supported by a previous report showing that overexpression of miR-210 have therapeutic effects on the cerebral ischemic mice [17] . In addition, we found that the same amount of EPC-EXs, EPC-EXs sc and EPC-EXs miR-210 was up-taken by H/R-injured ECs, which further supported our hypothesis that miR-210 played a boost effect on enhancing the beneficial effects of EPC-EXs. To further illustrate the mechanism of EPC-EXs miR-210 , we assessed the mitochondrial function of ECs. EPC-EXs miR-210 exhibited stronger effects than EPC-EXs or EPC-EXs sc on increasing MMP and ATP level, as well as decreasing mitochondrion fragmentation, reflecting the boost effect of miR-210 on EPC-EXs. In addition, we found that EPC-EXs miR-210 prominently restored H/R-induced dysregulations of mfn2 and drp1 on ECs. These finding suggest that miR-210 enrichment can boost the beneficial effects of EPC-EXs through improving mitochondria function. However, although we demonstrated a specific effect of miR-210 in EPC-EXs, we could not rule out the downstream functional targets, such as Efan3, Ptp1b, ISCU (iron-sulfur cluster scaffold homolog) and COX10 (cytochrome c oxidase assembly protein), which need further investigation. Efna3 and Ptp1b are involved in inhibition of angiogenesis and induction of apoptosis, respectively. Efna3 suppression in HUVEC cells is vital for stimulation of tubulogenesis, indicating its crucial function in angiogenesis [16] . Recently, it has been reported that Ptp1b is a negative regulator in VEGF signaling in ECs [40] . ISCU and COX10 are two important factors of the mitochondria Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry electron transport chain and the tricarboxylic acid cycle, which have been identified as potential targets of miR-210 [41] . Thus, the enhanced protective effects of EPC-EXs miR-210 on H/R-injured ECs might through direct regulation of these target genes.
In conclusion, EPC-EXs have protective effects on ECs against H/R injury through decreasing apoptosis, ROS production and improving angiogenic function. MiR-210 could enhance the protection effects of EPC-EXs on H/R-injured ECs mainly through improving mitochondrial function.
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